|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma (NSCLC) specimens. Please note…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana PD-L1 (SP263) Assay. This is…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC) cases. This is part 2 of a 3…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
|
Join the Roche Medical Affairs team discussing the role of artificial intelligence in clinical decision support. This workshop previously presented at USCAP 2021. Veeva MC-US-08974
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
|
Dr. Tom Wright is an internationally recognized expert who has been instrumental in key clinical trials driving the development of novel diagnostics in the field of cervical cancer. In his 48…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part 3 of a 4 part series. Content…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Linda Ahn from Roche Medical and Scientific Affairs team provides an introduction to the IMPACT trial data for use of biomarkers in cervical cancer triage. Part 2 of a 4 part series. Content…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Linda Ahn from Roche Medical and Scientific Affairs team discusses the current standard of care in cervical cancer screening. Part 1 of a 4 part series. Content and approvals of any product…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak from the Roche Diagnostics US Medical and Scientific Affairs team provides an overview of the new Ventana HER2 Dual ISH assay, comparison to the original assay and examples of…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 1 of a 3 part series Veeva #TE-US-01058
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from Roche Diagnostics MSA discusses SP263 immune cell scoring. This is part 3 of a 3 part series. Veeva TE-US-01059
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 2 of a 3 part series. Veeva TE-US-01057
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. Part 4 of a 4 part series. …
Content Declaration
Keep for 3 Years Language (In English)
English
|